These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22781963)

  • 1. Combining piracetam and lithium salts: ionic co-crystals and co-drugs?
    Braga D; Grepioni F; Maini L; Capucci D; Nanna S; Wouters J; Aerts L; Quéré L
    Chem Commun (Camb); 2012 Aug; 48(66):8219-21. PubMed ID: 22781963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydration Study of Piracetam Co-Crystal Hydrates.
    Liao X; Zhou N
    J Pharm Sci; 2018 Nov; 107(11):2804-2809. PubMed ID: 29969589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of position isomerism on the formation and physicochemical properties of pharmaceutical co-crystals.
    Liao X; Gautam M; Grill A; Zhu HJ
    J Pharm Sci; 2010 Jan; 99(1):246-54. PubMed ID: 19504586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural study of piracetam polymorphs and cocrystals: crystallography redetermination and quantum mechanics calculations.
    Tilborg A; Jacquemin D; Norberg B; Perpète E; Michaux C; Wouters J
    Acta Crystallogr B; 2011 Dec; 67(Pt 6):499-507. PubMed ID: 22101539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The solid-state characterization of fusidic acid.
    Gilchrist SE; Letchford K; Burt HM
    Int J Pharm; 2012 Jan; 422(1-2):245-53. PubMed ID: 22100514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrochloride salt co-crystals: preparation, characterization and physicochemical studies.
    Parmar VK; Shah SA
    Pharm Dev Technol; 2013; 18(2):443-53. PubMed ID: 22686294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal modification of dipyridamole using different solvents and crystallization conditions.
    Adhiyaman R; Basu SK
    Int J Pharm; 2006 Sep; 321(1-2):27-34. PubMed ID: 16842943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients.
    Vishweshwar P; McMahon JA; Peterson ML; Hickey MB; Shattock TR; Zaworotko MJ
    Chem Commun (Camb); 2005 Sep; (36):4601-3. PubMed ID: 16158128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular salts and co-crystals of mirtazapine with promising physicochemical properties.
    Sarkar A; Rohani S
    J Pharm Biomed Anal; 2015 Jun; 110():93-9. PubMed ID: 25818704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values.
    Javadzadeh Y; Mohammadi A; Khoei NS; Nokhodchi A
    Acta Pharm; 2009 Jun; 59(2):187-97. PubMed ID: 19564143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple approaches to pharmaceutical polymorphism investigation--a case study.
    Li H; Kiang YH; Jona J
    Eur J Pharm Sci; 2009 Dec; 38(5):426-32. PubMed ID: 19748574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Investigation into the Polymorphism and Crystallization of Levetiracetam and the Stability of its Solid Form.
    Xu K; Xiong X; Guo L; Wang L; Li S; Tang P; Yan J; Wu D; Li H
    J Pharm Sci; 2015 Dec; 104(12):4123-4131. PubMed ID: 26331706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the use of powder X-ray diffraction, Raman and near infrared spectroscopy for quantification of binary polymorphic mixtures of piracetam.
    Croker DM; Hennigan MC; Maher A; Hu Y; Ryder AG; Hodnett BK
    J Pharm Biomed Anal; 2012 Apr; 63():80-6. PubMed ID: 22333478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
    Attama AA; Müller-Goymann CC
    Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the preparation method on the physical-chemical properties of ketoprofen-cyclodextrin-phosphatidylcholine ternary systems.
    Cirri M; Maestrelli F; Mennini N; Mura P
    J Pharm Biomed Anal; 2009 Dec; 50(5):690-4. PubMed ID: 19097721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical co-crystals.
    Vishweshwar P; McMahon JA; Bis JA; Zaworotko MJ
    J Pharm Sci; 2006 Mar; 95(3):499-516. PubMed ID: 16444755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantages of cocrystallization in the field of solid-state pharmaceutical chemistry: L-Proline and MnCl(2).
    Tilborg A; Michaux C; Norberg B; Wouters J
    Eur J Med Chem; 2010 Aug; 45(8):3511-7. PubMed ID: 20493591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The study of different solid forms of Emodepside.
    Baronsky J; Bongaerts S; Traeubel M; Weiss HC; Urbanetz N
    Eur J Pharm Biopharm; 2009 Jan; 71(1):88-99. PubMed ID: 18602468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
    Maghsoodi M; Tajalli Bakhsh AS
    Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of supercritical fluid technology as preparative technique of benzocaine-cyclodextrin complexes--comparison with conventional methods.
    Al-Marzouqi AH; Jobe B; Dowaidar A; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2007 Jan; 43(2):566-74. PubMed ID: 17010552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.